APA (7th ed.) Citation

E, G., S, M. S., J, V., A, B., J, M., J, S., . . . FJ, A. (2021). Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy? Diagnostics (Basel, Switzerland), 11(8), . https://doi.org/10.3390/diagnostics11081335

Chicago Style (17th ed.) Citation

E, Gomez-Gomez, Moreno Sorribas S, Valero-Rosa J, Blanca A, Mesa J, Salguero J, Carrasco-Valiente J, López-Ruiz D, and Anglada-Curado FJ. "Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?" Diagnostics (Basel, Switzerland) 11, no. 8 (2021). https://doi.org/10.3390/diagnostics11081335.

MLA (9th ed.) Citation

E, Gomez-Gomez, et al. "Does Adding Standard Systematic Biopsy to Targeted Prostate Biopsy in PI-RADS 3 to 5 Lesions Enhance the Detection of Clinically Significant Prostate Cancer? Should All Patients with PI-RADS 3 Undergo Targeted Biopsy?" Diagnostics (Basel, Switzerland), vol. 11, no. 8, 2021, https://doi.org/10.3390/diagnostics11081335.